Mel Snyder

Pharma executives must take action amidst the U.S. drug price discourse. Here’s why.

The price of drugs in the U.S. has recently found itself at the centre of public scrutiny. As the...

How to differentiate new products within your portfolio…and from your competitors’

A rush to reignite growth should not remove the need for reflective consideration. In our second...

How to pick the best product candidate in the ‘new normal’

In the first of two related blogs exploring some of the impacts of the pandemic on commercial...